ERBB2 and breast carcinoma: Along this line, we previously reported that Her2+ breast cancer cells have an acute dependence on the ER-associated degradation pathway for survival, due to the severe proteotoxic stress imposed by the genomic amplification and hyper-active signaling by the Her2 oncogene [12].